Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo

By
Peter Fedichev, Quantum CTO
– August 9, 2011Posted in: docking, drug design, flue, influenza, publications

The manuscript entitled “” by the Quantum Team has been accepted to PLoS Currents Influenza. The reference:

Fedichev, Peter; Timakhov, Roman; Pyrkov, Tim; Getmantsev, Evgeny; Vinnik, Andrey. Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo [Internet]. Version 206. PLoS Currents: Influenza. 2011 Jul 11 [revised 2011 Aug 7]. Available from: http://knol.google.com/k/peter-fedichev/structure-based-drug-design-of-a-new/1nsjcj02vqpk8/1.

Related posts:

  1. Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  2. Services
  3. Beefing up the pipeline: new leads against influenza virus identified
  4. From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction
  5. Drug design, drug development, bioinformatics and preclinical services

About Peter Fedichev, Quantum CTO

Peter Fedichev, Ph.D., Chief Scientific Officer, co-founder